ClinConnect ClinConnect Logo
Search / Trial NCT00738790

Preoperative Radiotherapy and Local Excision in Rectal Cancer

Launched by POLISH COLORECTAL CANCER STUDY GROUP · Aug 19, 2008

Trial Information

Current as of April 30, 2025

Unknown status

Keywords

Rectal Cancer Preoperative Radiotherapy And Local Excision

ClinConnect Summary

Local excision must involve all tissue invaded on pretreatment examination. For this reason, 4-5 tatoos of mucosa at the tumour border should be performed before the onset of treatment. Next, the long-course radiochemotherapy or short-course radiotherapy is randomly allocated. After 6 weeks interval, the full thickness local excision should be carried out with 1 cm margin. Patients with good pathological response (complete response or downstaging to ypT1 disease)are followed up. Conversion to open surgery is offered to patients with poor pathological response (ypT2-3 or positive margin). Cl...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Biopsy proven good or moderately differentiated adenocarcinoma of rectum
  • Extraperitoneal tumour (\< 3-4 cm; unfavourable cT1 or cT2-3; N0)
  • No evidence of distant metastases on chest X-ray and abdominal CT or sonography
  • Signed by patient written informed consent
  • Exclusion Criteria:
  • Poorly differentiated pathology (G3)
  • Patients unfit for chemotherapy
  • No agreement for randomisation

About Polish Colorectal Cancer Study Group

The Polish Colorectal Cancer Study Group is a leading research consortium dedicated to advancing the understanding and treatment of colorectal cancer through innovative clinical trials. Comprising prominent oncologists, researchers, and healthcare professionals across Poland, the group focuses on multidisciplinary approaches to enhance patient outcomes and improve therapeutic strategies. By fostering collaboration among institutions and leveraging cutting-edge methodologies, the Polish Colorectal Cancer Study Group aims to contribute significantly to the global body of knowledge in colorectal cancer, ultimately striving to translate research findings into effective clinical practices for better patient care.

Locations

Warsaw, , Poland

Patients applied

0 patients applied

Trial Officials

Krzysztof Bujko, Prof.

Principal Investigator

Roentgena 5, 02-781 Warsaw, Poland

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials